The analysis of the possible mechanisms involved in COVID-19-induced neuropathology like PD. The analysis of pathways involved in the downregulation of ACE2 following SARS-CoV-2 infection and its effect on PD progression. This evidence concerns the gene ACE2 and Parkinson disease.